Exocrine Pancreatic Insufficiency and Functional Dyspepsia
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorMaria Marta Piskorz
About this trial
The goal of this observational study is to learn about the prevalence of exocrine pancreatic insufficiency in patients with functional dyspepsia .
. The main questions it aims to answer are: What is the prevalence of exocrine pancreatic insufficiency (EPI) in patients with functional dyspepsia? Wich are the clinical characteristics associated with (EPI) in patients with functional dyspepsia? Patients diagnosed with functional dyspepsia will undergo an evaluation of clinical symptoms and fecal elastase determination. In those with fecal elastase levels below 100 µg/g, an endoscopic ultrasound and other assessments will be performed to define the cause of exocrine pancreatic insufficiency (EPI).
Eligibility criteria
Qualifiers
Patients over 18 years of age diagnosed with functional dyspepsia based on Rome IV criteria, who have been excluded for organic, metabolic, and medication-related causes (NSAIDs), and who test negative for H. pylori.
Disqualifiers
Pregnancy or lactation
Organic diseases of the digestive tract (celiac disease, inflammatory bowel diseases, neoplasms, positive for H. pylori)
Uncontrolled systemic diseases (diabetes mellitus, hypo- or hyperthyroidism, cancer, etc.)
Lack of informed consent
Trial design
Treatments tested in this trial
- fecal elastase
- Serum cytokines
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Maria Marta Piskorz
Lead sponsor
Hospital de Clinicas José de San Martín
Sponsor institution
Source ClinicalTrials.gov